About RX Pharmatech
RX Pharmatech was founded in 2016 and is based in Bradford, United Kingdom. Operations focus on the cultivation and production of cannabis-derived items within the pharmaceutical sector. Products offered include CBD isolate as well as various finished formulations such as gummies, oils, drops, candies, tinctures, sprays, and capsules. These activities support distribution to relevant markets.
- Headquarter Bradford, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
22nd Century
(Jan 24, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RX Pharmatech
Detailed funding history for RX Pharmatech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RX Pharmatech
RX Pharmatech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 22nd Century.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of nicotine products
|
Locked | Locked | Locked |
Investor details for RX Pharmatech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RX Pharmatech
Investment portfolio details for RX Pharmatech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RX Pharmatech
Detailed financials for RX Pharmatech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rx Pharmatech Comparisons
Peer comparison for RX Pharmatech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RX Pharmatech
Detailed competitors of RX Pharmatech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rx Pharmatech
Complete news archive for RX Pharmatech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RX Pharmatech
RX Pharmatech was founded in 2016.
RX Pharmatech is headquartered in Bradford, United Kingdom. It is registered at Bradford, West Yorkshire, United Kingdom.
James A Mish is the current CEO of RX Pharmatech.
RX Pharmatech was founded in 2016 and is based in Bradford, United Kingdom. Operations focus on the cultivation and production of cannabis-derived items within the pharmaceutical sector. Products offered include CBD isolate as well as various finished formulations such as gummies, oils, drops, candies, tinctures, sprays, and capsules. These activities support distribution to relevant markets.
RX Pharmatech has 1 investor. Key investors include 22nd Century.